Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants

    NEXT STORY
    Global Sports Medicine Markets to 2024 – An $8.8 Billion Opportunity, Rising at a CAGR of 6%
    PREV STORY
    Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    XBiotech Announces First Patient in Clinical Study to Evaluate Bermekimab in Systemic Sclerosis

    author_avatar
    NASDAQ Market News

    2X Oncology to Present at Jefferies Global Healthcare Conference

    CAMBRIDGE, Mass., May 31, 2017 (GLOBE NEWSWIRE) -- 2X Oncology, Inc. ("2X" or the ...

    author_avatar
    NASDAQ Market News

    Sanofi Head of Global R&D Elias Zerhouni to retire; Company names John Reed to take over on July 1

    author_avatar
    NASDAQ Market News